Home > Focus Areas > Atopic Dermatitis Connect > Post
2yr
Discussion: This retrospective cohort study of patients enrolled in the KPNC healthcare system addresses an important gap in the scientific literature by describing IRs of malignancies in patients with moderate and severe AD.
Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36898743/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
-
Barbara Honig2yrWhile this subject clearly deserves further investigation, it is not surprising to learn about an increased incidence of malignancies such as NMSC and breast cancer in moderate to severe AD patients - since AD is an autoimmune disorder that is often treated with immunosuppressive traditional systemic and biologic agents.